FDA Inspection 1044228 — Vivimed Labs Usa

Vivimed Labs Usa — FEI 3008466097

The FDA completed an inspection of Vivimed Labs Usa on Mar 14, 2018 in Princeton Junction, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 14, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Princeton Junction, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673021 CFR 314.80(b)Failure to develop written procedures
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report
683021 CFR 314.80(c)(2)Interval
683221 CFR 314.80(c)(2)Late submission of annual safety reports
683321 CFR 314.80(c)(2)(ii)(A)Incomplete periodic safety report
891221 CFR 314.81(b)(2)Timely submission

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.